Short term variation in NTproBNP after lifestyle intervention in severe obesity

PLoS ONE

Volumn 12, Issue 7, 2017, Pages

  Fedele, Debora ^a   Bicchiega, Virginia ^b   Collo, Alessandro ^a   Barutta, Federica ^a   Pistone, Erika ^a   Gruden, Gabriella ^a   Bruno, Graziella ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b Auxology Institute   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ADULT; ARTICLE; BLOOD PRESSURE; BODY COMPOSITION; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIETARY INTAKE; FAT FREE MASS; FAT MASS; FEMALE; HEART FUNCTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LIFESTYLE MODIFICATION; LIPID ANALYSIS; MALE; OBESITY; PHYSICAL ACTIVITY; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; BLOOD; CONTROLLED CLINICAL TRIAL; KINESIOTHERAPY; LIFESTYLE; LOW CALORY DIET; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; OBESITY, MORBID; PROCEDURES; TIME FACTOR; TREATMENT OUTCOME; WEIGHT LOSS PROGRAM;

ADULT; COMBINED MODALITY THERAPY; DIET, REDUCING; EXERCISE THERAPY; FEMALE; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; OBESITY, MORBID; PEPTIDE FRAGMENTS; TIME FACTORS; TREATMENT OUTCOME; WEIGHT REDUCTION PROGRAMS;

EID: 85024501592     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0181212     Document Type: Article

References (26)

1. Nishikimi T, Kuwahara K, Nakao K. Current biochemistry, molecular biology, and clinical relevance of natriuretic peptides. J Cardiol 2011; 57:131-140 https://doi.org/10.1016/j.jjcc.2011.01.002 PMID: 21296556
2. Nishikimi T, Maeda N, Matsuoka H. The role of natriuretic peptides in cardioprotection. Cardiovasc Res 2006; 69:318-328 https://doi.org/10.1016/j.cardiores.2005.10.001 PMID: 16289003
3. Kim HN, Januzzi JL Jr. Natriuretic peptide testing in heart failure. Circulation 2011; 123:2015-2019 https://doi.org/10.1161/CIRCULATIONAHA.110.979500 PMID: 21555724
4. Di Angelantonio E, Chowdhury R, Sarwar N, et al. B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies. Circulation. 2009; 120:2177-2187 https://doi.org/10.1161/CIRCULATIONAHA.109.884866 PMID: 19917883
5. Tarnow L, Gall MA, Hansen BV, Hovind P, Parving HH. Plasma N-terminal pro-B-type natriuretic peptide and mortality in type 2 diabetes. Diabetologia 2006; 49: 2256-2262 https://doi.org/10.1007/s00125-006-0359-4 PMID: 16937127
6. Bruno G, Landi A, Barutta F, Ghezzo G, Baldin C, Spadafora L et al. NH2-terminal pro-brain natriuretic peptide is a stronger predictor of cardiovascular mortality than C-reactive protein and albumin excretion rate in elderly patients with type 2 diabetes: the Casale Monferrato population-based study. Diabetes Care 2013; 36: 2677-2682.
7. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Wilson PW et al. Impact of obesity on plasma natriuretic peptide levels. Circulation 2004; 109: 594-600 https://doi.org/10.1161/01.CIR.0000112582. 16683.EA PMID: 14769680
8. Madamanchi C, Alhosaini H, Sumida A, Runge MS. Obesity and natriuretic peptides, BNP and NTproBNP: mechanisms and diagnostic implications for heart failure. Int J Cardiol. 2014; 176:611-617 https://doi.org/10.1016/j.ijcard.2014.08.007 PMID: 25156856
9. Sanche OA, Duprez DA, Daniels LB, Maisel AS, Otvos JD, Peralta CA et al. The association between N-terminal pro B-type natriuretic peptide and lipoprotein particle concentration plateaus at higher N-terminal pro B-type natriuretic peptide values: Multi-Ethnic Study on Atherosclerosis. Metabolism 2015; 64: 857-861 https://doi.org/10.1016/j.metabol.2015.04.001 PMID: 25931335
10. Ricci MA, De Vuono S, Pucci G, Di Filippo F, Berisha S, Gentili A et al. Determinants of low levels of brain natriuretic peptide in morbid obesity. Clin Nutr. 2016;S0261-5614
11. Lazo M, Young JH, Brancati FL, Coresh J, Whelton S, Ndumele CE et al. NH2-Terminal Pro-Brain Natriuretic Peptide and Risk of Diabetes. Diabetes 2013; 62:3189-3193. https://doi.org/10.2337/db13-0478 PMID: 23733199
12. Pfister R, Sharp S, Luben R, Welsh P, Barroso I, Salomaa V et al. Mendelian randomization study of btype natriuretic peptide and type 2 diabetes. Evidence of causal association from population studies. PLoS Med 2011; 8:e1001112. https://doi.org/10.1371/journal.pmed.1001112 PMID: 22039354
13. Gruden G, Landi A, Bruno G. Natriuretic peptides, heart, and adipose tissue: new findings and future developments for diabetes research. Diabetes Care 2014; 37:2899-908 https://doi.org/10.2337/dc14-0669 PMID: 25342830
14. Clerico A, Giannoni A, Vittorini S, Emdin M. The paradox of low BNP levels in obesity. Heart Fail Rev 2012; 17:81-96 https://doi.org/10.1007/s10741-011-9249-z PMID: 21523383
15. Lavie CJ, Sharma A, Alpert MA, De Schutter A, Lopez-Jimenez F, Milani RV et al. Update on obesity and obesity paradox in heart failure. Prog Cardiovasc Dis 2016; 58:393-400 https://doi.org/10.1016/j. pcad.2015.12.003 PMID: 26721180
16. Collins S. A heart-adipose tissue connection in the regulation of energy metabolism. Nat Rev Endocrinol 2014; 10:157-163 https://doi.org/10.1038/nrendo.2013.234 PMID: 24296515
17. Chainani-Wu N, Weidner G, Purnell DM, Frenda S, Merritt-Worden T, Kemp C et al. Relation of B-type natriuretic peptide levels to body mass index after comprehensive lifestyle changes. Am J Cardiol. 2010; 105:1570-1576 https://doi.org/10.1016/j.amjcard.2010.01.016 PMID: 20494664
18. Kistorp C, Bliddal H, Goetze JP, Christensen R, Faber J. Cardiac natriuretic peptides in plasma increase after dietary induced weight loss in obesity. BMC Obes. 2014; 1: 24 https://doi.org/10.1186/s40608-014-0024-2 PMID: 26217511
19. Chen-Tournoux A, Khan AM, Baggish AL, Castro VM, Semigran MJ, McCabe EL et al. Effect of weight loss after weight loss surgery on plasma N-terminal pro-B-type natriuretic peptide levels. Am J Cardiol 2010; 106:1450-1455 https://doi.org/10.1016/j.amjcard.2010.06.076 PMID: 21059435
20. Changchien EM, Ahmed S, Betti F, Higa J, Kiely K, Hernandez-Boussard T et al. B-type natriuretic peptide increases after gastric bypass surgery and correlates with weight loss. Surg Endosc. 2011; 25:2338-2343 https://doi.org/10.1007/s00464-010-1565-1 PMID: 21424205
21. Gabrielsen AM, Omland T, Brokner M, Fredheim JM, Jordan J, Lehmann S et al. The effect of surgical and non-surgical weight loss on N-terminal pro-B-type natriuretic peptide and its relation to obstructive sleep apnea and pulmonary function. BMC Res Notes. 2016; 9:440 https://doi.org/10.1186/s13104-016-2241-x PMID: 27619215
22. Minami J, Nishikimi T, Ishimitsu T, Makino Y, Kawano Y, Takishita S et al. Effect of a hypocaloric diet on adrenomedullin and natriuretic peptides in obese patients with essential hypertension. J Cardiovasc Pharmacol. 2000; 36 Suppl 2:S83-6.
23. Pivovarova O, GögebakanÖ , Klö ting N, Sparwasser A, Weickert MO, Haddad I et al. Insulin up-regulates natriuretic peptide clearance receptor expression in the subcutaneous fat depot in obese subjects: a missing link between CVD risk and obesity? J Clin Endocrinol Metab. 2012; 97:E731-9 https://doi.org/10.1210/jc.2011-2839 PMID: 22419733
24. Moro C. Targeting cardiac natriuretic peptides in the therapy of diabetes and obesity. Expert Opin Ther Targets. 2016; 20:1445-1452 https://doi.org/10.1080/14728222.2016.1254198 PMID: 27786597
25. Coué M, Moro C. Natriuretic peptide control of energy balance and glucose homeostasis. Biochimie 2016; 124:84-91 https://doi.org/10.1016/j.biochi.2015.05.017 PMID: 26037452
26. Moro C. Does insulin resistance trigger natriuretic peptide deficiency? EBioMedicine. 2017; 17:11-12 https://doi.org/10.1016/j.ebiom.2017.03.005 PMID: 28284816